Ultromics Company

They are building world-class diagnostic aids to help cardiologists вАФ powered by artificial intelligence. To date, they have developed the worldвАЩs most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.


Estimated Revenue: $1M to $10M
Funding Status: Early Stage Venture
Headquarters: Oxford, Oxfordshire, United Kingdom
Total Funding: 58824943
Last Funding Date: 2021-08-16
Investors Number: 13
Founded Date: 2017-01-01
Technology: HealthCare Administration
Industry: Imaging
Last Funding Type: Series B
Employee Number: 11-50